Exercise study for prostate cancer patients pulled before it began
NCT ID NCT06282185
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aimed to see if a 12-week supervised exercise program could improve quality of life and physical fitness in men with advanced prostate cancer receiving hormone therapy. Participants would have been randomly assigned to either the supervised program or usual care with exercise advice. However, the study was withdrawn before enrolling any participants, so no data were collected.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- supervised exercise program
- What this could lead to
- If it works, this could show that structured exercise helps men with advanced prostate cancer feel better and stay fitter during hormone therapy.
- What could go wrong
- The study was withdrawn before enrolling anyone, so no results are available. Exercise may not significantly improve quality of life or fitness for all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Started
-
Nov 2024
- Finished
-
Sep 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 85 years
- Sex
-
Male participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Signed informed consent * Age \> 18 years old * Able to read and complete questionnaires in Dutch * Proven histologically and /or radiologically metastatic prostate cancer (TxNxM1) Exclusion Criteria: * Other cancers * Clinicians' judgement * Age \>80 years old or not able to walk 400m * Structural exercise (moderate-intensity exercise more than 150 minutes a week) during the past 3 months * Musculoskeletal, cardiovascular, or neurological disorders that could inhibit them from exercising * Spinal cord compression, history of pathological fractures
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Metastasis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Canisius Wilhelmina Ziekenhuis (CWZ)
Nijmegen, Gelderland, 6532SZ, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can pulsed radiation extend life in metastatic cervical cancer?
- Can MRI spot which prostate cancers are safe to watch?
- Robotic surgery vs standard approaches: does the platform change cancer outcomes?
- New antibody aims to preserve immune checkpoint while fighting cancer
- Two-Drug combo targets prostate cancer that outsmarts hormone therapy
- A sharper eye for cancer: new PET tracer targets hidden tumors